METASTATIC PANCREATIC ADENOCARCINOMA
Clinical trials for METASTATIC PANCREATIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PANCREATIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New chemo combo tested against tough pancreatic cancer
Disease control Recruiting nowThis study tests two different chemotherapy combinations in people with advanced pancreatic cancer that has spread or cannot be removed by surgery. About 52 adults will be randomly assigned to receive either NALIRIFOX or a modified gemcitabine-based regimen. The goal is to see wh…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated May 26, 2026 08:01 UTC
-
New hope for hard-to-treat pancreatic cancer: targeted drug combo enters final testing phase
Disease control Recruiting nowThis study tests whether adding the experimental drug setidegrasib to standard chemotherapy helps people with a specific type of advanced pancreatic cancer (KRAS G12D mutation) live longer. About 614 adults whose cancer has spread and cannot be removed by surgery will receive eit…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated May 26, 2026 07:56 UTC
-
New hope for pancreatic cancer: drug cocktail trial launches
Disease control Recruiting nowThis study tests a new drug (BMS-986340) plus standard treatments for advanced pancreatic cancer that has spread or returned. About 43 adults will receive the combination to see if it's safe and shrinks tumors. The goal is to find a better way to control this aggressive cancer.
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 07:54 UTC
-
Electromagnetic fields join the fight against pancreatic cancer
Disease control Recruiting nowThis study tests whether adding a special device that delivers amplitude-modulated radiofrequency electromagnetic fields (AM RF EMF) to standard chemotherapy can help people with metastatic pancreatic cancer. About 30 participants will receive the combination treatment. The main …
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated May 26, 2026 07:54 UTC
-
Tiny bubbles carrying gene-blocking cargo take on deadly pancreatic cancer
Disease control Recruiting nowThis early-phase study tests a new treatment for people with advanced pancreatic cancer that has a specific KRAS G12D mutation. The treatment uses tiny particles called exosomes to deliver a molecule that blocks the cancer-driving gene. The study aims to find the best dose and ch…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 07:25 UTC
-
Light and immune combo takes on tough pancreatic cancer
Disease control Recruiting nowThis study tests a new approach for people with pancreatic cancer that cannot be surgically removed. It combines a light-activated drug (verteporfin) with an immunotherapy (pembrolizumab) and standard chemotherapy. The goal is to see if this combination can shrink tumors better t…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 07:24 UTC
-
New triple therapy aims to tame tough pancreatic cancer
Disease control Recruiting nowThis study is testing a new combination of three drugs (S-1, nab-paclitaxel, and gemcitabine) in people whose pancreatic cancer has spread to other parts of the body. The goal is to find the safest and most effective dose and to see how well the drugs shrink tumors. About 70 part…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated May 26, 2026 07:24 UTC
-
Promising new combo aims to slow tough pancreatic cancer
Disease control Recruiting nowThis study tests whether adding a targeted drug called panitumumab to standard chemotherapy can help people with a specific type of advanced pancreatic cancer (KRAS wild-type) live longer. About 94 adults whose cancer has spread or can't be removed will receive either chemo alone…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New timing of chemo drugs could boost pancreatic cancer response
Disease control Recruiting nowThis study tests a new way of giving two chemotherapy drugs (gemcitabine and nab-paclitaxel) to people with pancreatic cancer that has spread. The goal is to see if changing the timing of the infusion helps shrink tumors better. About 67 participants will be enrolled, and the stu…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Anne Noonan • Aim: Disease control
Last updated May 18, 2026 12:09 UTC
-
New drug TR-002 tested for tough-to-treat cancers
Disease control Recruiting nowThis early-stage study tests a new chemotherapy drug, TR-002, in about 52 people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find the safest dose and check for side effects. The study also looks at whether the drug can shr…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Virtual coaching aims to ease the burden of pancreatic cancer on patients and families
Symptom relief Recruiting nowThis study tests whether telehealth self-management coaching sessions can improve quality of life for people with metastatic pancreatic cancer and their family caregivers. Participants will receive coaching on managing physical symptoms, emotional well-being, and social and spiri…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated May 26, 2026 07:56 UTC